Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.

Annals of internal medicine - 5 Jul 2011

Schousboe John T, Kerlikowske Karla, Loh Andrew, Cummings Steven R

Abstract excerpt

BACKGROUND: Current guidelines recommend mammography every 1 or 2 years starting at age 40 or 50 years, regardless of individual risk for breast cancer. OBJECTIVE: To estimate the cost-effectiveness of mammography by age, breast density, history of breast biopsy, family history of breast cancer, and screening interval. DESIGN: Markov microsimulation model. DATA SOURCES: Surveillance, Epidemiology, and End Results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to False Positive Reactions

Share to Mammography

Share to Markov Chains

Share to Quality-Adjusted Life Years

Share to Quality of Life

Source

Open in PubMed Open full text

Identifiers

PMID: 21727289
DOI: 10.7326/0003-4819-155-1-201107050-00003
PMCID: PMC3759993

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.PMID 21727289Read ↗

Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer PreventionSemantic proximity Read ↗

Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.Semantic proximity Read ↗

Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic VariantsSemantic proximity Read ↗

Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians.Semantic proximity Read ↗

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.Semantic proximity Read ↗

Assessing breast cancer risk within the general screening population: developing a breast cancer risk model to identify higher risk women at mammographic screening.Semantic proximity Read ↗

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.Semantic proximity Read ↗

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.Semantic proximity Read ↗

The current status of risk-stratified breast screening.Semantic proximity Read ↗

Association of Population Screening for Breast Cancer Risk With Use of Mammography Among Women in Medically Underserved Racial and Ethnic Minority Groups.Semantic proximity Read ↗

Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.Semantic proximity Read ↗

Online tool to guide decisions for BRCA1/2 mutation carriers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.